OGT certifies four CytoCell probes under IVDR for CLL and myeloma FISH testing, covering ATM deletion and IGH translocations NGS cannot yet replace ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and SPT Labtech today announced their partnership to deliver validated, automated library preparation workflows that combine Takara ...

As deep B cell depletion moves into autoimmune disease, antibody-directed allogeneic NK cell therapy may offer a different path to potency, scalability, and outpatient treatment.

PARSIPPANY, N.J.—Watson Pharmaceuticals Inc. has acquired Ascent Pharmahealth Ltd., the Australia and Southeast Asia generic pharmaceutical business of India-based Strides Arcolab Ltd., for AU$375 ...

Researchers ​are beginning to uncover differences in brain metabolism and cognitive performance among people with PMOS, but ...

Explore how enzymatic DNA synthesis can support longer, more complex constructs for genome editing, mRNA, and synthetic ...

The field of drug discovery is undergoing a profound transformation. Traditional small-molecule and biologic therapeutics — long the backbone of modern medicine — are now joined by a new generation of ...

Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across ...

Explore how dual binding assays reveal interactions between bispecific antibodies and their targets, providing insights into ...

The multi-omics data on nearly half a million tumor cells showed that even cells with almost identical genetic makeup can ...

This whitepaper outlines a practical framework for designing scientifically justified, regulatory-ready IND packages that ...

Welcome to the Weekly Rundown where the DDN editors cover this week’s top biotech and pharma news.